Nothing Special   »   [go: up one dir, main page]

WO2007143526A3 - Substituted tetrahydroimidazonaphthyridines and methods - Google Patents

Substituted tetrahydroimidazonaphthyridines and methods Download PDF

Info

Publication number
WO2007143526A3
WO2007143526A3 PCT/US2007/070181 US2007070181W WO2007143526A3 WO 2007143526 A3 WO2007143526 A3 WO 2007143526A3 US 2007070181 W US2007070181 W US 2007070181W WO 2007143526 A3 WO2007143526 A3 WO 2007143526A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
compounds
tetrahydroimidazonaphthyridines
substituted
naphthyridines
Prior art date
Application number
PCT/US2007/070181
Other languages
French (fr)
Other versions
WO2007143526A2 (en
Inventor
Joseph F Dellaria Jr
William H Moser
Matthew R Radmer
Tushar A Kshirsagar
Philip D Heppner
Original Assignee
Coley Pharm Group Inc
Joseph F Dellaria Jr
William H Moser
Matthew R Radmer
Tushar A Kshirsagar
Philip D Heppner
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coley Pharm Group Inc, Joseph F Dellaria Jr, William H Moser, Matthew R Radmer, Tushar A Kshirsagar, Philip D Heppner filed Critical Coley Pharm Group Inc
Publication of WO2007143526A2 publication Critical patent/WO2007143526A2/en
Publication of WO2007143526A3 publication Critical patent/WO2007143526A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

6,7,8,9-Tetrahydro-1H-imidazo[4,5-c]naphthyridines with a substituent at the 6-, 7-, 8-, or 9-position nitrogen atom, pharmaceutical compositions containing these compounds, methods of making the compounds, intermediates, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases, are disclosed.
PCT/US2007/070181 2006-06-05 2007-06-01 Substituted tetrahydroimidazonaphthyridines and methods WO2007143526A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80392706P 2006-06-05 2006-06-05
US60/803,927 2006-06-05

Publications (2)

Publication Number Publication Date
WO2007143526A2 WO2007143526A2 (en) 2007-12-13
WO2007143526A3 true WO2007143526A3 (en) 2008-02-07

Family

ID=38802237

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/070181 WO2007143526A2 (en) 2006-06-05 2007-06-01 Substituted tetrahydroimidazonaphthyridines and methods

Country Status (1)

Country Link
WO (1) WO2007143526A2 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2535117A1 (en) 2003-08-12 2005-03-03 3M Innovative Properties Company Oxime substituted imidazo-containing compounds
US7897597B2 (en) 2003-08-27 2011-03-01 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted imidazoquinolines
EP1660026A4 (en) 2003-09-05 2008-07-16 3M Innovative Properties Co Treatment for cd5+ b cell lymphoma
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
WO2005032484A2 (en) 2003-10-03 2005-04-14 3M Innovative Properties Company Alkoxy substituted imidazoquinolines
CA2545774A1 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Oxime substituted imidazo ring compounds
AU2004291122A1 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Hydroxylamine substituted imidazo ring compounds
CA2547020C (en) 2003-11-25 2014-03-25 3M Innovative Properties Company 1h-imidazo[4,5-c]pyridine-4-amine derivatives as immune response modifier
EP1701955A1 (en) 2003-12-29 2006-09-20 3M Innovative Properties Company Arylalkenyl and arylalkynyl substituted imidazoquinolines
WO2005066169A2 (en) 2003-12-30 2005-07-21 3M Innovative Properties Company Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides
US8697873B2 (en) 2004-03-24 2014-04-15 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
WO2005123080A2 (en) 2004-06-15 2005-12-29 3M Innovative Properties Company Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
US7915281B2 (en) 2004-06-18 2011-03-29 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
US7897609B2 (en) 2004-06-18 2011-03-01 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
US8026366B2 (en) 2004-06-18 2011-09-27 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
WO2006083440A2 (en) 2004-12-30 2006-08-10 3M Innovative Properties Company Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
AU2005322898B2 (en) 2004-12-30 2011-11-24 3M Innovative Properties Company Chiral fused (1,2)imidazo(4,5-c) ring compounds
EP1844201B1 (en) 2005-02-04 2016-08-24 3M Innovative Properties Company Aqueous gel formulations containing immune response modifiers
EP1846405A2 (en) 2005-02-11 2007-10-24 3M Innovative Properties Company Oxime and hydroxylamine substituted imidazo 4,5-c ring compounds and methods
JP2008535832A (en) 2005-04-01 2008-09-04 コーリー ファーマシューティカル グループ，インコーポレイテッド Pyrazolopyridine-1,4-diamine and analogs thereof
JP2008538550A (en) 2005-04-01 2008-10-30 コーリー ファーマシューティカル グループ，インコーポレイテッド 1-Substituted pyrazolo (3,4-c) cyclic compounds as modulators of cytokine biosynthesis for treating viral infections and neoplastic diseases
WO2008008432A2 (en) 2006-07-12 2008-01-17 Coley Pharmaceutical Group, Inc. Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods
KR102161364B1 (en) * 2015-09-14 2020-09-29 화이자 인코포레이티드 Imidazo[4,5-c]quinoline and imidazo[4,5-c][1,5]naphthyridine derivatives as LRRK2 inhibitors
WO2022204112A1 (en) * 2021-03-22 2022-09-29 Incyte Corporation Imidazole and triazole kras inhibitors

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194425B1 (en) * 1997-12-11 2001-02-27 3M Innovative Properties Company Imidazonaphthyridines
US6518280B2 (en) * 1998-12-11 2003-02-11 3M Innovative Properties Company Imidazonaphthyridines
US20040147543A1 (en) * 2002-12-20 2004-07-29 3M Innovative Properties Company Aryl substituted imidazoquinolines

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194425B1 (en) * 1997-12-11 2001-02-27 3M Innovative Properties Company Imidazonaphthyridines
US6518280B2 (en) * 1998-12-11 2003-02-11 3M Innovative Properties Company Imidazonaphthyridines
US20040147543A1 (en) * 2002-12-20 2004-07-29 3M Innovative Properties Company Aryl substituted imidazoquinolines

Also Published As

Publication number Publication date
WO2007143526A2 (en) 2007-12-13

Similar Documents

Publication Publication Date Title
WO2007143526A3 (en) Substituted tetrahydroimidazonaphthyridines and methods
MX2008002414A (en) Hydroxy substituted 1h-imidazopyridines and methods.
WO2005032484A3 (en) Alkoxy substituted imidazoquinolines
WO2007056112A3 (en) Hydroxy and alkoxy substituted 1h-imidazoquinolines and methods
WO2006086633A3 (en) Substituted fused [1,2]imidazo[4,5-c] ring compounds and methods
WO2006086449A3 (en) Alkyloxy substituted thiazoloquinolines and thiazolonaphthyridines
WO2006093514A3 (en) Aryl and arylalkylenyl substituted thiazoloquinolines and thiazolonaphthyridines
WO2005123080A3 (en) Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
WO2007106854A3 (en) Hydroxy and alkoxy substituted 1h-imidazonaphthyridines and methods
WO2005018556A3 (en) Hydroxylamine substituted imidazo-containing compounds
WO2006107853A3 (en) Pyrazolopyridine-1,4-diamines and analogs thereof
WO2008030511A3 (en) Substituted 3,4,6,7-tetrahydro-5h, 1,2a,4a,8-tetraazacyclopenta[cd]phenalenes
WO2007106852A3 (en) Substituted fused[1,2]imidazo[4,5-c] ring compounds and methods
MY145983A (en) Aryloxy and arylalkyleneoxy substituted imidazoquinolines
WO2006107753A3 (en) Pyrazolopyridines and analogs thereof
WO2005048945A3 (en) Hydroxylamine substituted imidazo ring compounds
WO2005123079A3 (en) Urea substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
WO2005079195A3 (en) Pyrazolopyridines and analogs thereof
WO2005094531A3 (en) Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
WO2005048933A3 (en) Oxime substituted imidazo ring compounds
WO2006038923A3 (en) Aryl substituted imidazonaphthyridines
WO2006091394A3 (en) Substituted imidazoquinolines and imidazonaphthyridines
WO2006091647A3 (en) Method of preferentially inducing the biosynthesis of interferon
WO2006026760A3 (en) 1-amino imidazo-containing compounds and methods
WO2006086634A3 (en) Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07797985

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07797985

Country of ref document: EP

Kind code of ref document: A2